Skip to main content
Geriatric Orthopaedic Surgery & Rehabilitation logoLink to Geriatric Orthopaedic Surgery & Rehabilitation
. 2021 Oct 5;12:21514593211044644. doi: 10.1177/21514593211044644

Predictors of In-Hospital Mortality in Older Adults Undergoing Hip Fracture Surgery: A Case–Control Study

Ming-Hsiu Chiang 1,*, Huan-Ju Lee 2,*, Yi-Jie Kuo 3,4, Pei-Chun Chien 3, Wei-Chun Chang 3, Yueh Wu 3, Yu-Pin Chen 3,4,
PMCID: PMC8495513  PMID: 34631200

Abstract

Introduction: Although surgery has been proven to improve the long-term survival of older adults with hip fracture, in-hospital mortality directly resulting from repair of hip fracture is undesirable. This study aimed to identify potential prognostic factors that predict in-hospital mortality risk in elderly patients following hip fracture surgery. Materials and Methods: This case–control study comprehensively collected data from older adults with hip fracture admitted to a single medical centre. Age was selected as the cross-matching factor. Univariate and binary multivariate logistic regression models were used to estimate the odds ratios with 95% confidence intervals. A receiver operating characteristic curve was constructed to quantify the discrimination power of the model. Results: Among a total of 841 older adults who received hip fracture surgery, 17 died during hospitalisation, yielding a 2.0% in-hospital mortality rate. Using a binary multivariate logistic regression model to perform a comparison with 51 age-matched patients in survival groups, the model revealed that estimated glomerular filtration rate (eGFR) and malignant cancer history were the only 2 factors significantly correlated with in-hospital mortality. The prognostic values for the eGFR and malignant cancer history were acceptable, with areas under the curve of .76 and .67, respectively. Conclusion: The prevalence of in-hospital mortality following hip fracture is low. After adjustment for age, eGFR and malignant cancer history were identified as factors significantly correlated with in-hospital mortality. The findings of this study could assist in the early screening and detection of patients with high in-hospital mortality risks.

Keywords: aged, hospital mortality, hip fractures, postoperative period, glomerular filtration rate

Introduction

Hip fracture is a serious and debilitating condition among older adults. As the general population has aged, the number of hip fractures has increased, and the total number is expected to reach 4.5 million by the year 2050. 1 In Asia, the number of hip fractures and cost of treatment are projected to, respectively, increase from 1,124,060 and US$9.5 billion in 2018 to 2,563,488 and US$15 billion in 2050. 2 Additionally, the number of hip fractures is expected to increase from 18 338 in 2010 to 50 421 in 2035 in Taiwan, 3 inevitably having serious socioeconomic impacts in the near future.

Although evidence has proven that hip fracture repair is effective in facilitating the recovery of mobility and elongating long-term survival periods among elderly patients with hip fracture, 4 surgery-related mortality is an undesirable complication, especially when the patient dies shortly after receiving the operation. The reported in-hospital mortality rate following hip fracture surgery ranges from 2.1% to 2.4%.5,6 Among several prognostic factors associated with postsurgical in-hospital mortality that have been reported in the literature, advanced age has been identified as the most important risk factor in elderly patients with hip fracture.7-9

In clinical practice, for patients and their families, the patient’s advanced age is one of the main factors contributing to the difficulty of deciding whether to opt for surgical repair. Knowledge of potential prognostic factors predictive of a high in-hospital mortality risk following hip fracture repair would enable clinicians to discuss with patients and their families potential fatal complications and alternative choices such as palliative treatment. 10 However, in addition to advanced age, which has been a major research focus, there remains a paucity of available data in the literature regarding other age-independent predictors. 11 The prevalence of in-hospital mortality following hip fracture surgery in older adults is also a topic for which relevant data are insufficient and further investigation is necessary. The aim of the present study was to identify the prevalence of and age-independent risk factors related to in-hospital mortality in vulnerable elderly patients following hip fracture repair.

Material and Methods

Study Population

This retrospective review included 842 patients older than 60 years who had been diagnosed as having extracapsular or intracapsular proximal femur fracture and who had received operations that included hemiarthroplasty or internal fixation with intramedullary nails, in situ cannulated screws, or dynamic hip screws at our institution in Taipei, Taiwan from January 2016 to August 2020. Patients were excluded if they received hip surgery for a condition other than primary hip fracture, such as for osteoarthritis, trauma, tumour metastasis, infection, or avascular necrosis of the femoral head. Among the 842 elderly patients with hip fracture, 17 died during their hospital stay after receiving hip fracture surgery, yielding an overall postsurgical in-hospital mortality rate of 2.0%.

This case–control study was conducted to compare the two age-matched groups of elderly patients with equivalent age but with different survival outcomes after hip surgery (ie, members of the in-hospital mortality group were compared with aged-matched members of the survival group, who lived for more than 3 months after discharge). Because advanced age has been regarded as one of the most critical factors influencing a patient’s prognosis, we paired the two groups by age to examine other potential age-independent clinical factors that may also greatly affect short-term outcomes of older adults with hip fracture. A 1:3 ratio was adopted, meaning that each participant in the in-hospital mortality group was paired by age to 3 other older adults with hip fracture who had survived for more than 3 months following surgery. Participants in the survival group were selected from our previously established databank for patients older than 60 years who underwent hip fracture repair at the same institution and with the same experienced orthopaedics team. 12

Measurement of Clinical Parameters

Basic demographic data, including age, sex, body mass index (BMI) and underlying comorbidities, were collected, along with laboratory data such as sodium level and preoperative and postoperative haemoglobin and creatinine levels and platelet and white blood cell counts. We also recorded the specific amount of time that elapsed between a patient’s fall and the time of operation. The operation records of each patient were screened to extract the following associated information: type of hip fracture, fracture location, blood loss during the operation, type of anesthesia, and duration of the operation.

Statistics

All statistical analyses were conducted using SPSS Statistics for Windows, version 18.0 (SPSS Inc., Chicago, IL, USA). Categorical variables are presented as frequencies and percentages, and continuous variables are presented as means ± standard deviations. Univariate analyses were conducted on risk factors that may be associated with in-hospital mortality in patients with hip fracture. Chi-squared and independent Student’s t tests were performed to compare categorical variables and continuous variables, respectively. Factors that differed significantly (P < .05) in the univariate analysis were included in the binary multivariate logistic regression model to estimate the odds ratios (ORs) with 95% confidence intervals (CIs). A receiver operating characteristic (ROC) curve was drawn for each significant risk factor in the binary multivariate logistic regression model. The area under the curve (AUC) was used to quantify the discriminative power of the ROC curve, and the Youden index was applied to identify the best cut-off point. For all tests, a two-sided P value of <.05 was considered statistically significant.

Results

The 17 older adults with hip fracture who died during their hospital stay shortly after receiving hip fracture surgery had a mean age of 86.5 ± 9.8 years (range 64–98 years) and average postoperative survival period of 12.0 ± 8.3 days. The causes of death of these 17 patients varied, with pneumonia being the highest prevalent (n = 7, 41%), followed by cardiovascular-related diseases (n = 4, 24%). The individual causes of death of the remaining 6 patients were intracerebral bleeding, renal failure, hepatic failure, sepsis and gastrointestinal bleeding (Table 1). After patients had been cross-matched by age, 51 patients who survived for more than 3 months after receiving hip fracture surgery were selected to serve as the control group. The mean age of the control group was 85.9 ± 9.4 years (Table 2).

Table 1.

Individual descriptions of patients in the in-hospital mortality group.

No Age (years) Type of Hip Fracture Surgery Direct Cause of Death Number of Postoperative Survival days
1 92 Dynamic hip screw Pneumonia 11
2 72 Cemented bipolar hemiarthroplasty Intracerebral haemorrhage 29
3 87 Cemented bipolar hemiarthroplasty Heart failure 2
4 82 Cemented bipolar hemiarthroplasty Arrhythmia 3
5 85 Proximal femoral nail Hepatic failure 13
6 98 Proximal femoral nail Pneumonia 3
7 96 Proximal femoral nail Renal failure, refuse haemodialysis 9
8 86 Dynamic hip screw Pneumonia 19
9 64 Cemented bipolar hemiarthroplasty Sepsis 15
10 84 Noncemented bipolar hemiarthroplasty ST-elevation and acute myocardial infarction 2
11 85 Dynamic hip screw Pneumonia 23
12 72 Cemented bipolar hemiarthroplasty Pulmonary embolism 17
13 87 Proximal femoral nail Pneumonia 5
14 96 Dynamic hip screw Aspiration pneumonia 7
15 93 Cemented bipolar hemiarthroplasty Heart failure 17
16 98 Cemented bipolar hemiarthroplasty Gastrointestinal bleeding 7
17 94 Dynamic hip screw Pneumonia 22

Table 2.

Comparison of clinical characteristics between groups of patients with hip fracture.

Clinical Characteristics Mean ± SD/Number (Percentage) P value
In-Hospital Mortality (n = 17) Control (n = 51)
Age (years) 86.5 ± 9.8 85.9 ± 9.4 0.8
Gender
Male
Female

10 (59%)
7 (41%)

21 (42%)
30 (58%)
0.2
Fracture type
Extracapsular
Intracapsular

10 (59%)
7 (41%)

30 (58%)
21 (42%)
0.9
Location
Right
Left

10 (59%)
7 (41%)

30 (58%)
21 (42%)
0.9
Time interval from hip fracture to operation (hours) 101.1 ± 128.2 47.7 ± 66.1 .03
Type of hip fracture surgery
Cemented bipolar hemiarthroplasty
Noncemented bipolar
hemiarthroplasty
Dynamic hip screw
Locking dynamic hip screw
Proximal femoral nail
Nail (Zimmer, natural nail)

7 (41%)
1 (6%)
5 (29%)
0
4 (24%)
0

14 (27%)
8 (16%)
6 (12%)
3 (6%)
17 (33%)
3 (6%)
0.2
Type of anaesthetic technique
Spinal anaesthesia
Endotracheal tube intubation
anaesthesia
Epidural anaesthesia
Intravenous general anaesthesia

9 (53%)
6 (35%)

1 (6%)
1 (6%)

28 (55%)
9 (18%)

14 (27%)
0
.049
Operation time (min) 77.1 ± 38.7 77.9 ± 23.4 0.9
Operation blood loss (mL) 139.4 ± 99.9 (n = 16) 103.5 ± 79.3 0.1
BMI 21.5 ± 4.8 22.2 ± 3.6 0.5
Underlying comorbidities
Hypertension
Diabetes mellitus
Valvular heart disease
Coronary artery disease
Chronic kidney disease
stage III a
Stage III b
Stage IV
Stage V
Cerebral vascular accident
Peptic ulcer history
Viral hepatitis
Dementia
Affective or psychotic disorder
Malignant cancer history

11 (65%)
6 (35%)
3 (18%)
3 (18%)
13 (77%)
2 (12%)
6 (35%)
4 (24%)
1 (6%)
1 (6%)
1 (6%)
3 (18%)
2 (12%)
2 (12%)
7 (41%)

34 (66%)
5 (10%)
13 (25%)
6 (12%)
21 (41%)
8 (16%)
10 (20%)
2 (4%)
1 (2%)
6 (12%)
6 (12%)
0
13 (25%)
8 (16%)
4 (8%)

1.0
.01
0.5
0.5
.02
0.5
0.5
.002
0.3
0.7
.01
Charlson Comorbidity Index 6.7 ± 2.0 4.7 ± 1.4 0.1
Cardiac echo (%) 63.9 ± 8.4 (n = 15) 68.2 ± 8.6 (n = 38) 0.1

Laboratory parameters
Na (mmol/L)
Preoperative Hb
Postoperative Hb
Platelet count
WBC count


137.2 ± 6.2
11.0 ± 1.4
10.2 ± 1.4
193.8 ± 82.7
12.5 ± 6.3


137.2 ± 3.3
12.8 ± 5.1
10.3 ± 1.7
206.8 ± 79.3
28.5 ± 93.3
1.0
0.1
0.9
0.6
0.5
Serum creatinine (mg/dL)* 1.8 ± 0.8 1.1 ± 0.6 <.001
eGFR 44.5 ± 28.6 73.6 ± 34.6 .003
Residence type
Lives with family
Lives in a nursing home
Lives alone or with nursing staff

11 (65%)
2 (12%)
4 (23%)

36 (71%)
3 (5%)
12 (24%)
0.7

*eGFR was chosen into the binary multivariate logistic regression model instead of serum creatinine.

Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; SD = standard deviation; WBC = white blood cell

Basic clinical characteristics of these 2 cohorts are listed in Table 2. The two groups did not differ significantly in terms of sex, BMI, laboratory parameters, residence type, type of hip fracture and fracture location. The results of the univariate analysis revealed significant between-group differences in the amount of time between the time of the fall to the time of operation, the type of anaesthesia used, the estimated glomerular filtration rate (eGFR), the proportion of patients with type 2 diabetes mellitus (DM), the proportion of patients with hepatitis and history of malignant cancer. Therefore, these 6 factors were included in the binary logistic multivariate regression model for further analysis.

In the binary logistic multivariate regression model, only eGFR and history of malignant cancer were significantly related to in-hospital mortality after hip fracture surgery (Supplementary Table). Additionally, DM had marginal significance (P = .073). A second binary logistic multivariate regression model was developed that included only significant and marginally significant predictors of in-hospital mortality from the first binary logistic multivariate regression model, which were eGFR, history of malignant cancer and DM. These variables had ORs of .96, 11.95 and 19.45, respectively (P values were .007, .007 and .002, respectively; Table 3). ROC curves were drawn for each of these 3 risk factors to test their respective diagnostic values (eGFR: AUC = .76, 95% CI = .62–90; malignant cancer history: AUC = .67, 95% CI = .50–83; DM: AUC = .63, 95% CI = .46–79). Youden index reached maximum when eGFR <35 mL/min/1.73 m2 was set as the cut-off point; the highest sensitivity and specificity were .90 and .59, respectively. Single application of malignant cancer history in predicting in-hospital mortality reached a sensitivity and specificity of .92 and .41, respectively (Figures 1A–C).

Table 3.

Second binary multivariate logistic regression model for the estimation of in-hospital mortality risk factors.

Variables Coefficient Odds Ratio 95% CI of Odds Ratio P value
Lower Limit Upper Limit
In-hospital mortality eGFR −.04 .96 .93 .99 .007
DM (yes) 2.5 11.95 1.95 73.03 .07
History of malignant cancer (yes) 3.0 19.45 3.11 121.54 .002

Abbreviations: CI, confidence interval; DM, type 2 diabetes mellitus; eGFR, estimated glomerular filtration rate.

Figure 1.

Figure 1.

Receiver operating characteristic (ROC) curve and area under curve (AUC) of (A) estimated glomerular filtration rate, (B) malignant cancer, and (C) diabetes mellitus.

Discussion

In the present study, each patient’s clinical history was thoroughly reviewed, and all serum samples were obtained within 24 h after admission, thus ensuring the comprehensiveness and reliability of the data. After patients were cross-matched by age, our results suggested that eGFR, DM and history of malignant cancer were the three most important age-independent risk factors predictive of the postoperative prognosis of older adults with hip fracture.

The long-term mortality rate following hip fracture surgery is high. A Korean nationwide retrospective study reported that the mortality rate of patients with hip fracture was twice as high as that of the general population at a mean follow-up period of 4.45 years. 13 However, in-hospital mortality after hip fracture surgery is rare and could result in a considerable psychological burden for orthopaedic surgeons and the patient’s family. Studies have reported that 2.1% to 2.4% of patients with hip fracture die during hospitalisation,5,6 which is comparable to the results of the present study. Male gender, the use of conservative treatment, advanced age and the presence of comorbid conditions on admission were identified as significant risk factors for in-hospital mortality in patients with hip fracture.7,14 Moreover, a UK study compared patients who died within 48 h after hip fracture surgery with those who survived more than 1 year after hip fracture surgery and found that the former were older and more likely to be receiving institutional care or to have fallen in the hospital. An American Society of Anesthesiologists physical classification system grade higher than 3, mental impairment and impaired mobility were also highly related to 48 h postoperative mortality. 11

Kidney function is a key factor in determining the long-term outcomes of patients with hip fracture. In a large population-based cohort study of 44 065 diabetic patients with different stages of renal function after hip fracture surgery, patients undergoing dialysis had the highest rates of mortality and short‐ and long‐term complications at 3 months and 1 year after surgery, followed by patients with chronic kidney disease (CKD) and those without CKD. 15 Patients with CKD were reported to have a high risk of malnutrition, anaemia and electrolyte imbalances; in particular, they had problems with calcium metabolism that disrupted bone remodelling and mineralisation (renal osteodystrophy). 16 Moreover, receiving dialysis is commonly associatedwith increased production of inflammatory cytokines and functional defects in the immune system, thus putting patients at an increased risk of infection.17,18 A Korean retrospective study categorised 119 patients with hip fracture into CKD and non-CKD groups and found that the CKD group had a significantly lower 5-year survival rate than that of the non-CKD group; moreover, 27% of patients in the CKD group experienced complications, whereas complications were reported in only 11.9% of patients in the non-CKD group. Infections and prosthesis dislocation were the two most common postoperative complications reported in the CKD group. 19 In the present study, the 77% of patients who died during their hospital stay had different stages of CKD, and nearly half of them died of pneumonia. This finding suggests that a more thorough preoperative risk assessment should be applied, along with intensive postoperative care. 20

A strength of the present study was that the timing of each hip fracture occurrence was reported by patients or their caregivers rather than being extracted from their admission or emergency records. Although the time between fracture occurrence and surgery was not significant in the binary logistic multivariate regression model, it was still a factor that potentially affected the likelihood of survival after hip fracture. Multiple studies have investigated matters related to surgery delay in patients with hip fracture. A Norwegian observational study of 83 727 patients with hip fracture found no differences in mortality if the fracture-to-surgery time was within 48 h; however, 3-day and 1-year postoperative mortality rates increased significantly when the fracture-to-surgery time exceeded 48 h. 21 Another large observational study reported that mortality increased significantly with increasing time between fracture occurrence and surgery. 22 Moreover, Fu et al. reported that performing surgery on patients with hip fracture within 24 h after admission could significantly reduce the risk of respiratory complications, including pneumonia, extubation failure and reintubation. 23 However, a recent randomised controlled trial reported no significance differences regarding mortality or major complications between patients who received accelerated surgery and those who received standard care. We posit that this between-study discrepancy could be the result of different fracture-to-surgery times; all patients in the randomised controlled trial received surgery within 48 h after hip fracture occurrence, 24 whereas other studies included patients who had longer fracture-to-surgery times. In the present study, the average fracture-to-surgery time in the in-hospital mortality group exceeded 4 days. Although we did not record the exact reasons for these delays, we suspect that the serious comorbidities in these patients interfered with hospital transportation, the decision to operate and the creation of plans for anaesthesia.

Types of anaesthesia differed between in-hospital mortality and control groups in the univariate analysis. Compared with the control group, the in-hospital mortality group included more patients who received general anaesthesia through endotracheal tube intubation and fewer patients who received epidural anaesthesia. Waesberghe et al. performed a meta-analysis and examined the outcomes of general and neuraxial (spinal and epidural) anaesthesia in patients with hip fracture and identified significantly lower rates of in-hospital mortality among the neuraxial anaesthesia group (OR .85, P = .004) but no difference in 30-day mortality rate between patients who received these two types of anaesthesia. 25 Moreover, two other retrospective cohort studies that focused on older adults with hip fracture also reported no difference in 30-day mortality rates between these two types of anaesthesia,26,27 and another study reported that spinal anaesthesia was associated with fewer and less severe adverse effects. 27 In fact, an increased use of spinal anaesthesia over general anaesthesia in older adults with hip fracture has already been observed, which may be attributable to lower interventional morbidity in older patients with frailty. 28

Several in-hospital mortality prediction models for patients with hip fracture have been proposed, but no reliable prediction model has been well documented. Karres et al. applied six prediction models to 1050 patients with hip fracture, and none of the models yielded convincing discrimination in predicting 30-day mortality. 29 Similarly, Nelson et al. directly compared three well-known predictive models for mortality in elderly patients following hip fracture: the Age-Adjusted Charlson Comorbidity Index, 30 the Physiological and Operative Severity Score for enUmeration of Mortality and Morbidity 31 and the Nottingham Hip Fracture Score. 9 Using acceptable AUC values, the authors concluded that these three models did not differ significantly in mortality prediction accuracy. 32 Future studies with larger sample sizes are warranted to establish an optimal scoring system for predicting short-term mortality in older adults with hip fracture. The three age-independent risk factors identified in the present study could nevertheless aid clinicians’ decision-making regarding hip fracture surgery for older adults.

Limitations

This study had several limitations. First, only 68 participants were retrospectively enrolled; thus, the study findings cannot represent the overall condition of older adults with hip fracture. Second, this study was conducted in the Taipei City metropolitan area, meaning that the findings may not be representative of the epidemiology of hip fracture among residents of urban areas in Taiwan. Third, limitations inherent in the retrospective investigation of medical records prevented us from being able to collect several important clinical parameters that may be highly correlated with in-hospital mortality, such as mental condition, preinjury mobility status and the use of medication. Additional studies with larger sample sizes are warranted to follow the natural course and assess the clinical effect of these risk factors in older adults shortly after they receive hip fracture surgery.

Conclusion

This case–control study identified poor renal function, malignant cancer history, and DM as three significant age-independent risk factors for in-hospital mortality in older adults undergoing hip fracture surgery. Renal function had an acceptable AUC value; when eGFR <35 mL/min/1.73 m2 was set as the cut-off point, patients vulnerable to in-hospital mortality following hip fracture surgery could be identified with high sensitivity.

Acknowledgements

The authors are grateful to like to acknowledge the Laboratory Animal Center at TMU for the English editing support and to Taipei Medical University (Grant numbers TMU110-AE1-B07) for financially supporting this research.

Footnotes

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Taipei Medical University (Grant numbers TMU110-AE1-B07).

Ethical Approval: The Ethical Committee of Taipei Medical University approved the entire protocol and all instruments used (ethical approval number: TMU-JIRB N201709053). All participants consented to their inclusion in the study and the publication of data.

ORCID iD

Yu-Pin Chen https://orcid.org/0000-0002-9729-6375

References

  • 1.Cooper C, Cole ZA, Cole ZA, et al. Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011;22(5):1277-1288. doi: 10.1007/s00198-011-1601-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cheung C-L, Ang SB, Chadha M, et al. An updated hip fracture projection in Asia: The Asian Federation of Osteoporosis Societies study. Osteoporosis and Sarcopenia. 2018;4(1):16-21. doi: 10.1016/j.afos.2018.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chen I-J, Chiang C-YF, Li Y-H, et al. Nationwide cohort study of hip fractures: time trends in the incidence rates and projections up to 2035. Osteoporos Int. 2015;26(2):681-688. doi: 10.1007/s00198-014-2930-z. [DOI] [PubMed] [Google Scholar]
  • 4.Parker M, Johansen A. Hip fracture. Bmj. 2006;333(7557):27-30. doi: 10.1136/bmj.333.7557.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Prieto-Alhambra D, Reyes C, Sainz MS, et al. In-hospital care, complications, and 4-month mortality following a hip or proximal femur fracture: The Spanish registry of osteoporotic femur fractures prospective cohort study. Archives of osteoporosis. 2018;13(1):96. doi: 10.1007/s11657-018-0515-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Civinini R, Paoli T, Cianferotti L, et al. Functional outcomes and mortality in geriatric and fragility hip fractures-results of an integrated, multidisciplinary model experienced by the “Florence hip fracture unit”. Int Orthop. 2019;43(1):187-192. doi: 10.1007/s00264-018-4132-3. [DOI] [PubMed] [Google Scholar]
  • 7.Frost SA, Nguyen ND, Black DA, Eisman JA, Nguyen TV. Risk factors for in-hospital post-hip fracture mortality. Bone. 2011;49(3):553-558. doi: 10.1016/j.bone.2011.06.002. [DOI] [PubMed] [Google Scholar]
  • 8.Endo A, Baer HJ, Nagao M, Weaver MJ. Prediction Model of In-Hospital Mortality After Hip Fracture Surgery. J Orthop Trauma. 2018;32(1):34-38. doi: 10.1097/BOT.0000000000001026. [DOI] [PubMed] [Google Scholar]
  • 9.Maxwell MJ, Moran CG, Moppett IK. Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery. Br J Anaesth. 2008;101(4):511-517. doi: 10.1093/bja/aen236. [DOI] [PubMed] [Google Scholar]
  • 10.Sullivan NM, Blake LE, George M, Mears SC. Palliative care in the hip fracture patient. Geriatric Orthopaedic Surgery & Rehabilitation. 2019;10:215145931984980. doi: 10.1177/2151459319849801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nkanang B, Parker M, Parker E, Griffiths R. Perioperative mortality for patients with a hip fracture. Injury. 2017;48(10):2180-2183. doi: 10.1016/j.injury.2017.07.007 [DOI] [PubMed] [Google Scholar]
  • 12.Chen Y-P, Wong P-K, Tsai M-J, et al. The high prevalence of sarcopenia and its associated outcomes following hip surgery in Taiwanese geriatric patients with a hip fracture. J Formos Med Assoc. 2020;119(12):1807-1816. doi: 10.1016/j.jfma.2020.02.004. [DOI] [PubMed] [Google Scholar]
  • 13.Choi HG, Lee YB, Rhyu SH, Kwon BC, Lee JK.Mortality and cause of death postoperatively in patients with a hip fracture.The Bone & Joint Journal. 2018;100-B(4):436-442. doi: 10.1302/0301-620X.100B4.BJJ-2017-0993.R2. [DOI] [PubMed] [Google Scholar]
  • 14.Shoda N, Yasunaga H, Horiguchi H, et al. Risk factors affecting inhospital mortality after hip fracture: retrospective analysis using the Japanese Diagnosis Procedure Combination Database. BMJ open. 2012;2(3):e000416. doi: 10.1136/bmjopen-2011-000416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Huang PH, Chen TH, Lin YS, et al. Chronic Kidney Disease Worsens Health Outcomes in Diabetic Patients After Hip Fracture Surgery: An Asian Nationwide Population‐Based Cohort Study. J Bone Miner Res. 2019;34(5):849-858. doi: 10.1002/jbmr.3663 [DOI] [PubMed] [Google Scholar]
  • 16.Moe SM. Calcium Homeostasis in Health and in Kidney Disease.Comprehensive Physiology. 2016;6(4):1781-1800. doi: 10.1002/cphy.c150052. [DOI] [PubMed] [Google Scholar]
  • 17.Betjes MGH. Immune cell dysfunction and inflammation in end-stage renal disease.Nat Rev Nephrol. 2013;9(5):255-265. doi: 10.1038/nrneph.2013.44. [DOI] [PubMed] [Google Scholar]
  • 18.Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758-1764. doi: 10.1111/j.1523-1755.2000.00337.x. [DOI] [PubMed] [Google Scholar]
  • 19.Suh Y-S, Won SH, Choi H-S, et al. Survivorship and complications after hip fracture surgery in patients with chronic kidney disease. J Kor Med Sci. 2017;32(12):2035-2041. doi: 10.3346/jkms.2017.32.12.2035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chang S-C, Lai J-I, Lu M-C, et al. Reduction in the incidence of pneumonia in elderly patients after hip fracture surgery. Medicine. 2018;97(33):e11845. doi: 10.1097/MD.0000000000011845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Leer-Salvesen S, Engesæter LB, Dybvik E, Furnes O, Kristensen TB, Gjertsen J-E.Does time from fracture to surgery affect mortality and intraoperative medical complications for hip fracture patients?.The Bone & Joint Journal. 2019;101-B(9):1129-1137. doi: 10.1302/0301-620X.101B9.BJJ-2019-0295.R1 [DOI] [PubMed] [Google Scholar]
  • 22.Beaupre LA, Khong H, Smith C, et al. The impact of time to surgery after hip fracture on mortality at 30- and 90-days: Does a single benchmark apply to all?. Injury. 2019;50(4):950-955. doi: 10.1016/j.injury.2019.03.031. [DOI] [PubMed] [Google Scholar]
  • 23.Fu MC, Boddapati V, Gausden EB, Samuel AM, Russell LA, Lane JM. Surgery for a fracture of the hip within 24 hours of admission is independently associated with reduced short-term post-operative complications.The Bone & Joint Journal. 2017;99-B(9):1216-1222. doi: 10.1302/0301-620X.99B9.BJJ-2017-0101.R1. [DOI] [PubMed] [Google Scholar]
  • 24.Borges FK, Bhandari M, Guerra-Farfan E, et al. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial.Lancet (London, England). 2020;395(10225):698-708. doi: 10.1016/S0140-6736(20)30058-1. [DOI] [PubMed] [Google Scholar]
  • 25.Van Waesberghe J, Stevanovic A, Rossaint R, Coburn M. General vs. neuraxial anaesthesia in hip fracture patients: a systematic review and meta-analysis. BMC Anesthesiol. Jun 28 2017;17(1):87. doi: 10.1186/s12871-017-0380-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gremillet C, Jakobsson JG. Acute hip fracture surgery anaesthetic technique and 30-day mortality in Sweden 2016 and 2017: A retrospective register study. F1000Research. 2018;7:1009. doi: 10.12688/f1000research.15363.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Basques BA, Bohl DD, Golinvaux NS, Samuel AM, Grauer JG. General versus spinal anaesthesia for patients aged 70 years and older with a fracture of the hip.The Bone & Joint Journal. 2015;97-B(5):689-695. doi: 10.1302/0301-620X.97B5.35042. [DOI] [PubMed] [Google Scholar]
  • 28.Maxwell BG, Spitz W, Porter J. Association of increasing use of spinal anesthesia in hip fracture repair with treating an aging patient population. JAMA Surgery. 2020;155:167. doi: 10.1001/jamasurg.2019.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Karres J, Heesakkers NA, Ultee JM, Vrouenraets BC. Predicting 30-day mortality following hip fracture surgery: Evaluation of six risk prediction models. Injury. 2015;46(2):371-377. doi: 10.1016/j.injury.2014.11.004 [DOI] [PubMed] [Google Scholar]
  • 30.Neuhaus V, King J, Hageman MG, Ring DC. Charlson comorbidity indices and in-hospital deaths in patients with hip fractures. Clin Orthop Relat Res. 2013;471(5):1712-1719. doi: 10.1007/s11999-012-2705-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Copeland GP, Jones D, Walters M. POSSUM: A scoring system for surgical audit. Br J Surg. 2005;78(3):355-360. doi: 10.1002/bjs.1800780327 [DOI] [PubMed] [Google Scholar]
  • 32.Nelson MJ, Scott J, Sivalingam P. Evaluation of Nottingham hip fracture score, age-adjusted Charlson comorbidity index and the physiological and operative severity score for the enumeration of mortality and morbidity as predictors of mortality in elderly neck of femur fracture patients. SAGE Open Medicine. 2020;8:205031212091826. doi: 10.1177/2050312120918268. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Geriatric Orthopaedic Surgery & Rehabilitation are provided here courtesy of SAGE Publications

RESOURCES